"FDA Probes Hair Loss and Mental Health Concerns in Obesity and Diabetes Drug Side Effects"

The FDA is investigating reports of potential serious side effects, including hair loss and suicidal thoughts, associated with the use of Wegovy and similar weight loss drugs. These drugs, which have been effective in clinical trials for obesity treatment, are now under scrutiny for adverse events reported post-approval. While these reports do not establish causation, they have prompted the FDA to consider regulatory actions, which could range from updated drug labeling to more severe restrictions if the risks are found to outweigh the benefits.